Tower Research Capital (TRC)’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-896
Closed -$41K 4726
2018
Q3
$41K Buy
+896
New +$43.4K ﹤0.01% 1893
2017
Q4
Sell
-3,293
Closed -$143K 4364
2017
Q3
$143K Buy
3,293
+3,193
+3,193% +$146K 0.01% 1030
2017
Q2
$5K Buy
+100
New +$4.66K ﹤0.01% 2052
2016
Q4
Sell
-1,140
Closed -$61K 4754
2016
Q3
$61K Sell
1,140
-1,212
-52% -$56.3K 0.01% 1039
2016
Q2
$101K Buy
2,352
+2,252
+2,252% +$94.5K 0.01% 1102
2016
Q1
$5K Sell
100
-124
-55% -$5.96K ﹤0.01% 2800
2015
Q4
$14K Buy
+224
New +$15.3K ﹤0.01% 1733
2015
Q2
Sell
-520
Closed -$23K 5356
2015
Q1
$23K Buy
520
+295
+131% +$13.1K ﹤0.01% 2154
2014
Q4
$11K Buy
225
+197
+704% +$7.89K ﹤0.01% 2094
2014
Q3
$1K Sell
28
-478
-94% -$13K ﹤0.01% 4228
2014
Q2
$13K Sell
506
-141
-22% -$3.64K ﹤0.01% 2176
2014
Q1
$36K Sell
647
-431
-40% -$24.8K ﹤0.01% 1350
2013
Q4
$52K Sell
1,078
-2,484
-70% -$105K 0.01% 1364
2013
Q3
$149K Buy
3,562
+3,540
+16,091% +$169K 0.02% 969
2013
Q2
$1K Buy
+22
New +$863 ﹤0.01% 3793

Other funds holding IMPV

Tower Research Capital (TRC)'s IMPV Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 896 shares — an estimated $41K sold.

Tower Research Capital (TRC) first reported a position in IMPV in Q2 2013 and held it in 15 quarters. The position peaked at $149K in Q3 2013. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Tower Research Capital (TRC) reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 896 Imperva, Inc. shares in Q4 2018, an estimated $41K.
  • Tower Research Capital (TRC) first reported a position in Imperva, Inc. in Q2 2013 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s Imperva, Inc. position peaked at $149K in Q3 2013.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.